Korea Bio-Gen Co.,Ltd (KOSDAQ:A318000) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its common stock, pursuant to a contract with Mirae Asset Daewoo Co., Ltd. The purpose of the program is to stabilize the stock prices and enhance the shareholders’ value. The program will end on September 16, 2020. As of March 16, 2020, the company had no shares in treasury within the scope available for dividend and no shares in treasury through other repurchase.